PERRIGO Co plc (PRGO) stock

PRGONYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3029% below fair value

$16.24+0.06 (+0.37%)

Close on Nov 13, 2026Market cap $2.25BP/E –Yield 7.14%

Perrigo EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Perrigo's EV/EBITDA was 8.5× on Jan 30, 2026, against 21.3× a year earlier. Over the last 5 years it ranged from 8.3× to 24.5×, with a median of 15.0×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Jan 30, 2026	8.5×	+0.1
2025	Dec 31, 2025	8.4×	−13.2
2024	Dec 31, 2024	21.6×	+7.8
2023	Dec 29, 2023	13.8×	−6.3
2022	Dec 30, 2022	20.1×	+11.0
2021	Dec 31, 2021	9.0×	−6.3
2020	Dec 31, 2020	15.3×	+1.3
2019	Dec 31, 2019	14.1×	+2.7
2018	Dec 31, 2018	11.4×	−4.9
2017	Dec 29, 2017	16.3×	−2.4
2016	Dec 30, 2016	18.7×	−9.7
2015	Dec 31, 2015	28.4×	−2.0
2014	Dec 31, 2014	30.3×	+13.4
2013	Oct 31, 2013	16.9×	–